House Bill 6213
116th Congress(2019-2020)
No Cost for COVID–19 Testing Act
Introduced
Introduced in House on Mar 11, 2020
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
6213
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Frederica Wilson
grade
Florida
Arizona
California
Colorado
Connecticut
Connecticut
Florida
Georgia
Maryland
Michigan
Michigan
New York
Northern Mariana Islands
Oregon
Virginia
Washington
Washington
Washington
No House votes have been held for this bill.
Summary
No Cost for COVID–19 Testing Act
This bill requires private health insurance plans to cover testing for COVID-19 (i.e., coronavirus disease 2019) without imposing cost sharing for the duration of the public health emergency declared on January 31, 2020. This includes the cost of administering such approved tests and visits to health care providers for testing.
March 11, 2020
Sort by most recent
03/11/2020
Referred to the Subcommittee on Health.
03/11/2020
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Labor, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
03/11/2020
Introduced in House
Public Record
Record Updated
Feb 9, 2022 1:57:10 AM